GlassScriptPhysician profile
Jason Michael Cochran
NPI 1013039759
$8,679.47
in general payments reported to CMS, 2019-2025
25 companies · $472 in 2025
The $472 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,375 · 2020: $399 · 2021: $352 · 2022: $3,430 · 2023: $1,614 · 2024: $1,038 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,116 · Travel and Lodging: $7.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,115.93 |
| Travel and Lodging | $7.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,339.49 | 2019-2024 | Triathlon, Mako, Insignia |
| Smith+Nephew, INC. | $1,018.10 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Healicoil, Bone Anchors With Arthroscopic Delivery System |
| Abbott Laboratories | $359.02 | 2021-2022 | |
| Heron Therapeutics, INC. | $278.74 | 2021-2023 | Aponvie |
| Vericel Corporation | $187.04 | 2021-2025 | Maci |
| Davol INC. | $165.68 | 2023-2024 | Arista Ah Flexitip |
| Abbvie INC. | $153.61 | 2022-2023 | Dalvance |
| Depuy Synthes Sales INC. | $147.91 | 2024 | Attune |
| Amgen INC. | $145.02 | 2019-2024 | Evenity |
| Boston Scientific Corporation | $128.08 | 2021-2025 | General - Pain Management |
| Si-Bone, INC. | $118.41 | 2022 | |
| Pacira Therapeutics, INC. | $117.93 | 2019-2020 | |
| Next Science LLC | $104.69 | 2024 | Xperience, Blastx, Surgx |
| Ferring Pharmaceuticals INC. | $72.05 | 2019-2025 | Euflexxa |
| Orthofix Medical, INC. | $70.87 | 2020-2025 | Cervical-Stim, Physio-Stim |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $59.38 | 2019-2024 | |
| Integra Lifesciences Corporation | $58.25 | 2023 | Tenoglide |
| Radius Health, INC. | $47.78 | 2019-2024 | Tymlos |
| Melinta Therapeutics, LLC | $25.84 | 2019 | |
| Alexion Pharmaceuticals, INC. | $18.75 | 2019 | |
| Kci USA, INC. | $13.54 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.09 | 2023 | |
| Bioventus LLC | $12.66 | 2019 | |
| Convatec INC. | $12.35 | 2019 | |
| Medtronic USA, INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Cochran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.